The Estonian Court of appeal confirms the right of third parties to challenge merger decisions, but upholds the Competition Authority’s merger clearance concerning the acquisition of a company controlling a chain of pharmacies (Magnum Medical / Parimex Invest)

On 14 June 2005, the Tallinn Circuit Court (a court of appeal) issued a judgment upholding the Estonian Competition Authority's (ECA) merger clearance concerning the acquisition of OÜ Parimex Invest, a company controlling a chain of pharmacies, by AS Magnum Medical, an Estonian dominant wholesaler of pharmaceuticals. The judgment focused on three main issues: (i) the right to challenge the ECA's merger decisions by third parties; (ii) the impact of pharmaceuticals regulation on merger control decisions; (iii) the definition of relevant markets. As regards the right to challenge the ECA's merger decisions, the ECA contended that only the parties to the concentration and not any

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

Katri Paas-Mohando, The Estonian Court of appeal confirms the right of third parties to challenge merger decisions, but upholds the Competition Authority’s merger clearance concerning the acquisition of a company controlling a chain of pharmacies (Magnum Medical / Parimex Invest), 14 juin 2005, e-Competitions June 2005, Art. N° 21335

Visites 235

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues